XML 52 R109.htm IDEA: XBRL DOCUMENT v2.4.0.6
Discontinued Operations (Schedule Revenue From Subsidiaries) (Detail) (Segment, Discontinued Operations [Member], USD $)
In Millions, unless otherwise specified
12 Months Ended
Dec. 31, 2012
Dec. 31, 2011
Dec. 31, 2010
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business $ 1,202.6 $ 1,242.0 $ 1,125.6
EDT [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   177.9 274.1
EDT [Member] | Product [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   168.0 261.4
EDT [Member] | Product [Member] | TriCor 145 [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   35.5 54.5
EDT [Member] | Product [Member] | Focalin XR/Ritalin LA [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   25.9 33.0
EDT [Member] | Product [Member] | Ampyra [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   22.6 56.8
EDT [Member] | Product [Member] | Verelan [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   18.1 21.8
EDT [Member] | Product [Member] | Naprelan [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   5.9 12.6
EDT [Member] | Product [Member] | Skelaxin [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business     5.9
EDT [Member] | Product [Member] | Other [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   60.0 76.8
EDT [Member] | Contract Revenue [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   9.9 12.7
EDT [Member] | Contract Revenue [Member] | Research Contracts [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   6.0 8.2
EDT [Member] | Contract Revenue [Member] | Milestone Payments [Member]
     
Income Statement, Balance Sheet and Additional Disclosures by Disposal Groups, Including Discontinued Operations [Line Items]      
Revenue from the EDT business   $ 3.9 $ 4.5